This site is intended for healthcare professionals
Breast cancer

Future breast cancer care: ESMO Breast Cancer 2024

Supported by Pierre Fabre Medicament
Last updated: 30th May 2024
Published:30th May 2024

Welcome to our coverage of ESMO Breast Cancer 2024, held in Berlin, Germany, on 15–17 May 2024. Read on for the latest advances in early breast cancer treatment, as well as innovative approaches for metastatic and triple-negative breast cancers.


Developed independently by EPG Health, which received educational funding from Pierre Fabre Medicament awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.